nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—Taste metallic—Metformin—polycystic ovary syndrome	0.0444	0.117	CcSEcCtD
Eszopiclone—CYP2C9—urine—polycystic ovary syndrome	0.0234	0.0906	CbGeAlD
Eszopiclone—Heartburn—Metformin—polycystic ovary syndrome	0.0205	0.054	CcSEcCtD
Eszopiclone—CYP3A4—urine—polycystic ovary syndrome	0.0178	0.0691	CbGeAlD
Eszopiclone—GABRG3—pituitary gland—polycystic ovary syndrome	0.0166	0.0645	CbGeAlD
Eszopiclone—Accidental injury—Metformin—polycystic ovary syndrome	0.016	0.042	CcSEcCtD
Eszopiclone—Neuropathy—Metformin—polycystic ovary syndrome	0.0133	0.0349	CcSEcCtD
Eszopiclone—Lightheadedness—Metformin—polycystic ovary syndrome	0.0126	0.0333	CcSEcCtD
Eszopiclone—TSPO—embryo—polycystic ovary syndrome	0.0124	0.0481	CbGeAlD
Eszopiclone—Ear pain—Metformin—polycystic ovary syndrome	0.012	0.0316	CcSEcCtD
Eszopiclone—GABRA4—pituitary gland—polycystic ovary syndrome	0.0116	0.045	CbGeAlD
Eszopiclone—Injury—Metformin—polycystic ovary syndrome	0.0112	0.0294	CcSEcCtD
Eszopiclone—TSPO—adrenal cortex—polycystic ovary syndrome	0.0102	0.0394	CbGeAlD
Eszopiclone—Migraine—Metformin—polycystic ovary syndrome	0.0101	0.0266	CcSEcCtD
Eszopiclone—GABRG2—pituitary gland—polycystic ovary syndrome	0.00971	0.0376	CbGeAlD
Eszopiclone—Dehydration—Metformin—polycystic ovary syndrome	0.00954	0.0251	CcSEcCtD
Eszopiclone—Cramp muscle—Metformin—polycystic ovary syndrome	0.00923	0.0243	CcSEcCtD
Eszopiclone—GABRA3—endocrine gland—polycystic ovary syndrome	0.00923	0.0358	CbGeAlD
Eszopiclone—TSPO—endometrium—polycystic ovary syndrome	0.00908	0.0352	CbGeAlD
Eszopiclone—Influenza—Metformin—polycystic ovary syndrome	0.00886	0.0233	CcSEcCtD
Eszopiclone—GABRA2—adipose tissue—polycystic ovary syndrome	0.00884	0.0342	CbGeAlD
Eszopiclone—TSPO—uterus—polycystic ovary syndrome	0.00836	0.0324	CbGeAlD
Eszopiclone—TSPO—pituitary gland—polycystic ovary syndrome	0.00821	0.0318	CbGeAlD
Eszopiclone—TSPO—adipose tissue—polycystic ovary syndrome	0.00818	0.0317	CbGeAlD
Eszopiclone—GABRA2—adrenal gland—polycystic ovary syndrome	0.00793	0.0307	CbGeAlD
Eszopiclone—Drowsiness—Metformin—polycystic ovary syndrome	0.0079	0.0208	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00775	0.0204	CcSEcCtD
Eszopiclone—GABRA2—vagina—polycystic ovary syndrome	0.00735	0.0285	CbGeAlD
Eszopiclone—TSPO—adrenal gland—polycystic ovary syndrome	0.00734	0.0284	CbGeAlD
Eszopiclone—Rhinitis—Metformin—polycystic ovary syndrome	0.00711	0.0187	CcSEcCtD
Eszopiclone—Hepatitis—Metformin—polycystic ovary syndrome	0.00709	0.0187	CcSEcCtD
Eszopiclone—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00706	0.0186	CcSEcCtD
Eszopiclone—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00699	0.0184	CcSEcCtD
Eszopiclone—TSPO—female gonad—polycystic ovary syndrome	0.00684	0.0265	CbGeAlD
Eszopiclone—TSPO—vagina—polycystic ovary syndrome	0.0068	0.0264	CbGeAlD
Eszopiclone—Chills—Metformin—polycystic ovary syndrome	0.00637	0.0168	CcSEcCtD
Eszopiclone—TSPO—endocrine gland—polycystic ovary syndrome	0.00636	0.0247	CbGeAlD
Eszopiclone—CYP2C8—endometrium—polycystic ovary syndrome	0.00623	0.0241	CbGeAlD
Eszopiclone—Dysgeusia—Metformin—polycystic ovary syndrome	0.00605	0.0159	CcSEcCtD
Eszopiclone—Muscle spasms—Metformin—polycystic ovary syndrome	0.00594	0.0156	CcSEcCtD
Eszopiclone—Vision blurred—Metformin—polycystic ovary syndrome	0.00582	0.0153	CcSEcCtD
Eszopiclone—Tremor—Metformin—polycystic ovary syndrome	0.00579	0.0152	CcSEcCtD
Eszopiclone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00573	0.0151	CcSEcCtD
Eszopiclone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00564	0.0218	CbGeAlD
Eszopiclone—Malaise—Metformin—polycystic ovary syndrome	0.00557	0.0147	CcSEcCtD
Eszopiclone—Palpitations—Metformin—polycystic ovary syndrome	0.00546	0.0144	CcSEcCtD
Eszopiclone—Hypertension—Metformin—polycystic ovary syndrome	0.00533	0.014	CcSEcCtD
Eszopiclone—Myalgia—Metformin—polycystic ovary syndrome	0.00526	0.0138	CcSEcCtD
Eszopiclone—Chest pain—Metformin—polycystic ovary syndrome	0.00526	0.0138	CcSEcCtD
Eszopiclone—Discomfort—Metformin—polycystic ovary syndrome	0.00519	0.0137	CcSEcCtD
Eszopiclone—PTGS1—endometrium—polycystic ovary syndrome	0.00505	0.0196	CbGeAlD
Eszopiclone—Infection—Metformin—polycystic ovary syndrome	0.00501	0.0132	CcSEcCtD
Eszopiclone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00487	0.0128	CcSEcCtD
Eszopiclone—Anorexia—Metformin—polycystic ovary syndrome	0.0048	0.0126	CcSEcCtD
Eszopiclone—CYP2C8—vagina—polycystic ovary syndrome	0.00467	0.0181	CbGeAlD
Eszopiclone—PTGS1—uterus—polycystic ovary syndrome	0.00465	0.018	CbGeAlD
Eszopiclone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00459	0.0121	CcSEcCtD
Eszopiclone—PTGS1—pituitary gland—polycystic ovary syndrome	0.00457	0.0177	CbGeAlD
Eszopiclone—PTGS1—adipose tissue—polycystic ovary syndrome	0.00455	0.0176	CbGeAlD
Eszopiclone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00453	0.0119	CcSEcCtD
Eszopiclone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00449	0.0118	CcSEcCtD
Eszopiclone—Somnolence—Metformin—polycystic ovary syndrome	0.00448	0.0118	CcSEcCtD
Eszopiclone—Dyspepsia—Metformin—polycystic ovary syndrome	0.00444	0.0117	CcSEcCtD
Eszopiclone—Decreased appetite—Metformin—polycystic ovary syndrome	0.00438	0.0115	CcSEcCtD
Eszopiclone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00437	0.0169	CbGeAlD
Eszopiclone—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00435	0.0115	CcSEcCtD
Eszopiclone—Fatigue—Metformin—polycystic ovary syndrome	0.00435	0.0114	CcSEcCtD
Eszopiclone—Constipation—Metformin—polycystic ovary syndrome	0.00431	0.0113	CcSEcCtD
Eszopiclone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00415	0.0109	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00412	0.0108	CcSEcCtD
Eszopiclone—PTGS1—adrenal gland—polycystic ovary syndrome	0.00408	0.0158	CbGeAlD
Eszopiclone—Urticaria—Metformin—polycystic ovary syndrome	0.004	0.0105	CcSEcCtD
Eszopiclone—Abdominal pain—Metformin—polycystic ovary syndrome	0.00398	0.0105	CcSEcCtD
Eszopiclone—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00388	0.015	CbGeAlD
Eszopiclone—PTGS1—female gonad—polycystic ovary syndrome	0.00381	0.0148	CbGeAlD
Eszopiclone—PTGS1—vagina—polycystic ovary syndrome	0.00378	0.0147	CbGeAlD
Eszopiclone—Asthenia—Metformin—polycystic ovary syndrome	0.00362	0.00952	CcSEcCtD
Eszopiclone—Pruritus—Metformin—polycystic ovary syndrome	0.00357	0.00939	CcSEcCtD
Eszopiclone—PTGS1—endocrine gland—polycystic ovary syndrome	0.00354	0.0137	CbGeAlD
Eszopiclone—Diarrhoea—Metformin—polycystic ovary syndrome	0.00345	0.00908	CcSEcCtD
Eszopiclone—Dizziness—Metformin—polycystic ovary syndrome	0.00333	0.00877	CcSEcCtD
Eszopiclone—Vomiting—Metformin—polycystic ovary syndrome	0.0032	0.00843	CcSEcCtD
Eszopiclone—Rash—Metformin—polycystic ovary syndrome	0.00318	0.00836	CcSEcCtD
Eszopiclone—Dermatitis—Metformin—polycystic ovary syndrome	0.00317	0.00836	CcSEcCtD
Eszopiclone—Headache—Metformin—polycystic ovary syndrome	0.00316	0.00831	CcSEcCtD
Eszopiclone—Nausea—Metformin—polycystic ovary syndrome	0.00299	0.00788	CcSEcCtD
Eszopiclone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00296	0.0115	CbGeAlD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000518	0.00143	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000515	0.00142	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000503	0.00139	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000503	0.00139	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000502	0.00139	CbGpPWpGaD
Eszopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000497	0.00137	CbGpPWpGaD
Eszopiclone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000495	0.00137	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000484	0.00134	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00048	0.00133	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000479	0.00132	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000477	0.00132	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000474	0.00131	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000458	0.00126	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00045	0.00124	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00045	0.00124	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000447	0.00124	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000443	0.00122	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000442	0.00122	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000441	0.00122	CbGpPWpGaD
Eszopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000439	0.00121	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000439	0.00121	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000439	0.00121	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000438	0.00121	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000437	0.00121	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000434	0.0012	CbGpPWpGaD
Eszopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000433	0.0012	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000433	0.0012	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000431	0.00119	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000422	0.00116	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000421	0.00116	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000414	0.00114	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000409	0.00113	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000409	0.00113	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000408	0.00113	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.000407	0.00112	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000407	0.00112	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000403	0.00111	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000403	0.00111	CbGpPWpGaD
Eszopiclone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000403	0.00111	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.0004	0.0011	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000399	0.0011	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000397	0.0011	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000392	0.00108	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000386	0.00107	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000385	0.00106	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000381	0.00105	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000378	0.00104	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000372	0.00103	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000369	0.00102	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000369	0.00102	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000368	0.00102	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00036	0.000994	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000358	0.00099	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000356	0.000983	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000356	0.000983	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000355	0.000981	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000353	0.000976	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000352	0.000973	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000352	0.000972	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000351	0.000969	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000348	0.00096	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000347	0.000958	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000347	0.000958	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000347	0.000958	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000346	0.000955	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000343	0.000948	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000338	0.000935	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000337	0.000932	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000334	0.000921	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000328	0.000907	CbGpPWpGaD
Eszopiclone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000327	0.000904	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000325	0.000898	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000324	0.000895	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000322	0.00089	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000319	0.000881	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000315	0.000869	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00031	0.000857	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00031	0.000856	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	0.00031	0.000856	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00031	0.000855	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000302	0.000834	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000301	0.000831	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000297	0.00082	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000296	0.000819	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000296	0.000817	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000295	0.000816	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000295	0.000814	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000292	0.000808	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000291	0.000803	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00029	0.000801	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000289	0.000798	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000287	0.000792	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	0.000283	0.000783	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	0.000283	0.000783	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000283	0.000782	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000283	0.000781	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00028	0.000773	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000276	0.000761	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000265	0.000733	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000264	0.000729	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	0.000264	0.000728	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000263	0.000726	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	0.000263	0.000726	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00026	0.000718	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000258	0.000711	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000252	0.000697	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000247	0.000683	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000241	0.000665	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00024	0.000664	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000235	0.00065	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000235	0.000648	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000234	0.000647	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000231	0.000639	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000231	0.000637	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000231	0.000637	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000228	0.00063	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000228	0.000629	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.000224	0.000619	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.000224	0.000619	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000224	0.000617	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000221	0.00061	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000215	0.000595	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000214	0.000592	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000214	0.000592	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000214	0.000591	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000212	0.000586	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00021	0.000579	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000209	0.000579	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000204	0.000563	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000199	0.00055	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000196	0.000541	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000193	0.000533	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000189	0.000522	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000188	0.000519	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000187	0.000515	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000186	0.000513	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000182	0.000504	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000182	0.000504	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000178	0.000492	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000178	0.00049	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000175	0.000484	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000173	0.000477	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000172	0.000475	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.00017	0.000469	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000168	0.000464	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000166	0.000459	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000166	0.000458	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000159	0.00044	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000158	0.000437	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000157	0.000434	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000156	0.000431	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000153	0.000422	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000152	0.00042	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000152	0.00042	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000151	0.000418	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000149	0.00041	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000146	0.000404	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000145	0.0004	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000144	0.000399	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000143	0.000394	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000141	0.000391	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000141	0.000389	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000138	0.000382	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000137	0.000377	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000135	0.000374	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000132	0.000364	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000129	0.000355	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000127	0.000349	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000125	0.000344	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000123	0.00034	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000123	0.00034	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00012	0.000332	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00012	0.000332	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000118	0.000325	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000116	0.000321	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000116	0.00032	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000115	0.000317	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000111	0.000307	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00011	0.000304	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000107	0.000296	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.000107	0.000296	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000105	0.000289	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000103	0.000285	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000103	0.000284	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000102	0.000282	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000102	0.000281	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000101	0.00028	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000101	0.000279	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000101	0.000278	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	9.84e-05	0.000272	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	9.6e-05	0.000265	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.55e-05	0.000264	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	9.45e-05	0.000261	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	9.34e-05	0.000258	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	9.33e-05	0.000258	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.11e-05	0.000252	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	9.04e-05	0.00025	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	8.72e-05	0.000241	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	8.7e-05	0.00024	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	8.37e-05	0.000231	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.32e-05	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	8.27e-05	0.000228	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.21e-05	0.000227	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	8.17e-05	0.000226	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.12e-05	0.000224	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	7.95e-05	0.00022	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	7.81e-05	0.000216	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.75e-05	0.000214	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	7.69e-05	0.000212	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	7.48e-05	0.000206	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.07e-05	0.000195	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	7.05e-05	0.000195	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—POMC—polycystic ovary syndrome	6.96e-05	0.000192	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—INS—polycystic ovary syndrome	6.92e-05	0.000191	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.91e-05	0.000191	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.69e-05	0.000185	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	6.67e-05	0.000184	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TH—polycystic ovary syndrome	6.65e-05	0.000184	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	6.47e-05	0.000179	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	6.36e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.16e-05	0.00017	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	6.08e-05	0.000168	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	6.03e-05	0.000166	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.96e-05	0.000165	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.75e-05	0.000159	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	5.62e-05	0.000155	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.52e-05	0.000153	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.45e-05	0.000151	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	5.43e-05	0.00015	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.17e-05	0.000143	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.15e-05	0.000142	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.07e-05	0.00014	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.9e-05	0.000135	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	4.57e-05	0.000126	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	4.56e-05	0.000126	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	4.49e-05	0.000124	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	4.47e-05	0.000123	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.39e-05	0.000121	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.27e-05	0.000118	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.01e-05	0.000111	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.71e-05	0.000102	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.66e-05	0.000101	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.64e-05	0.0001	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.58e-05	9.89e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.41e-05	9.42e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.23e-05	8.93e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.02e-05	8.33e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.45e-05	6.75e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.41e-05	6.66e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.4e-05	6.62e-05	CbGpPWpGaD
